Cargando…
1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781810/ http://dx.doi.org/10.1093/ofid/ofu052.752 |
_version_ | 1783295045342855168 |
---|---|
author | Sakoulas, George Umeh, Obiamiwe Huntington, Jennifer Cloutier, Daniel Steenbergen, Judith Yuan, Guojun Yoon, Minjung Goldstein, Ellie |
author_facet | Sakoulas, George Umeh, Obiamiwe Huntington, Jennifer Cloutier, Daniel Steenbergen, Judith Yuan, Guojun Yoon, Minjung Goldstein, Ellie |
author_sort | Sakoulas, George |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5781810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57818102018-03-01 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial Sakoulas, George Umeh, Obiamiwe Huntington, Jennifer Cloutier, Daniel Steenbergen, Judith Yuan, Guojun Yoon, Minjung Goldstein, Ellie Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781810/ http://dx.doi.org/10.1093/ofid/ofu052.752 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
spellingShingle | IDWeek 2014 Abstracts Sakoulas, George Umeh, Obiamiwe Huntington, Jennifer Cloutier, Daniel Steenbergen, Judith Yuan, Guojun Yoon, Minjung Goldstein, Ellie 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial |
title | 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial |
title_full | 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial |
title_fullStr | 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial |
title_full_unstemmed | 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial |
title_short | 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial |
title_sort | 1044 efficacy of ceftolozane/tazobactam vs levofloxacin in the treatment of complicated urinary tract infections (cuti) caused by levofloxacin-resistant pathogens: results from the aspect-cuti trial |
topic | IDWeek 2014 Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781810/ http://dx.doi.org/10.1093/ofid/ofu052.752 |
work_keys_str_mv | AT sakoulasgeorge 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT umehobiamiwe 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT huntingtonjennifer 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT cloutierdaniel 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT steenbergenjudith 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT yuanguojun 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT yoonminjung 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial AT goldsteinellie 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial |